AMZN
Amazon.com, Inc.
AMZN's outlook is improving, though it still trails on the overall score.
BKNG
Booking Holdings Inc.
BKNG has a slight edge over AMZN overall, supported by stronger valuation and stronger fundamentals.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
BKNG Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Strong | |
| Healthy |
BKNG's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over BKNG in the historical PE scenario, which offers more potential upside but is not a forecast.
BKNG PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 14x | $161 | — |
| Current | 17x | $161 | — |
| Cheap | 23x | $212 | +32% |
| Fair | 32x | $294 | +82% |
| Expensive | 128x | $1,188 | +637% |
Historical ranges are pointers, not guarantees.
BKNG's PE is in its cheap range at 17x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
BKNG Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Moderate |
BKNG has the edge over AMZN on the outlook, with more favorable valuation expectations.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over BKNG on earnings, with more consistent year-over-year improvement.
BKNG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $11.78 | +27% |
| Q3 2026 | $9.25 | +51% |
| Q2 2026 | $9.01 | +57% |
| Q1 2026 | $7.58 | +18% |
| Q4 2025 | $6.62 | -4.2% |
| Q3 2025 | $6.14 | +4.6% |
| Q2 2025 | $5.74 | +0.9% |
| Q1 2025 | $6.42 | +21% |
| Q4 2024 | $6.91 | +47% |
BKNG earned $9.25 per share over the past year, up 51% from the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN's revenue has grown year over year every quarter since late 2020: $202B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN's operating margin was 14% last quarter, up 4.2 points from the same quarter a year ago, near the top of its range since 2019.
BKNG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $8.9B | -1.3% |
| Q2 2026 | $7.4B | +8.1% |
| Q1 2026 | $5.5B | +16% |
| Q4 2025 | $6.3B | +16% |
| Q3 2025 | $9B | +13% |
| Q2 2025 | $6.8B | +16% |
| Q1 2025 | $4.8B | +7.9% |
| Q4 2024 | $5.5B | +14% |
BKNG's revenue is growing: $8.9B last quarter, down 1.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 38% | -0.2 points |
| Q2 2026 | 34% | +0.9 points |
| Q1 2026 | 23% | +0.7 points |
| Q4 2025 | 32% | +0.4 points |
| Q3 2025 | 39% | -1.1 points |
| Q2 2025 | 33% | +1.4 points |
| Q1 2025 | 22% | +4.4 points |
| Q4 2024 | 32% | +19 points |
BKNG has the edge over AMZN on profitability, with a higher operating margin.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
BKNG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.1B | -22% |
| Q2 2026 | $3.6B | +16% |
| Q1 2026 | $3.1B | -1.7% |
| Q4 2025 | $1.4B | +120% |
| Q3 2025 | $1.4B | -40% |
| Q2 2025 | $3.1B | +32% |
| Q1 2025 | $3.2B | +23% |
| Q4 2024 | $645M | -48% |
BKNG has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
BKNG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.2% | -17M shares |
| 1 year | -7.5% | -61M shares |
| 3 years | -16% | -147M shares |
| 5 years | -27% | -281M shares |
| Available history | -31% | -335M shares |
BKNG has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $2.1B |
| Q2 2026 | $4B |
| Q1 2026 | $3.8B |
| Q4 2025 | $2.1B |
| Q3 2025 | $653M |
| Q2 2025 | $1.5B |
| Q1 2025 | $2.2B |
| Q4 2024 | $1.2B |
BKNG spent $12B buying back its own shares over the past year, up 117% from the year before.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
BKNG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.4x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | 0.1x | Very low |
| Q2 2025 | 0.1x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 0.1x | Very low |
BKNG has the edge over AMZN on leverage, with a lower net debt burden relative to earnings.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
BKNG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.1 | Neutral |
| Stochastic | 14.6 | Oversold |
BKNG's weekly RSI is 43 (neutral) and its Stochastic is 15 (oversold).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
BKNG PE vs Consumer Cyclical Sector
| Metric | BKNG | Sector median | Relative |
|---|---|---|---|
| PE | 17x | 18x | 3.3% below |
| PE % | 4 | 47 | 43 pts below |
BKNG has the edge over AMZN on valuation relative to its sector.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over BKNG on trend strength, trading above more of its moving averages.
BKNG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $159.1 | 1.3% above |
| 20 week MA | $178.2 | 9.5% below |
| 50 week MA | $180.8 | 11% below |
| 100 week MA | $193.2 | 17% below |
| 200 week MA | $164.3 | 1.9% below |
BKNG has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 1.9% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over BKNG on returns for 2026, with the stronger performance.
BKNG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $82.9 | $83.5 | +0.8% |
| 2021 | $83.5 | $96.1 | +15% |
| 2022 | $96.1 | $78.9 | -18% |
| 2023 | $78.9 | $141.9 | +80% |
| 2024 | $141.9 | $201.5 | +42% |
| 2025 | $201.5 | $217.6 | +8% |
| 2026 YTD | $217.6 | $161.2 | -26% |
BKNG has finished higher in five of the last six years. It's down 26% so far in 2026.